2025

Niva Bupa Health Insurance IPO GMP: Is This Your Next Profitable Investment?

by Surya raghav

The Niva Bupa Health Insurance IPO is set to open for subscription on November 7, 2024, and will close on November 11, 2024. With a target to raise ₹2,200 crore, the IPO comprises a fresh issue of ₹800 crore and an offer for sale (OFS) of ₹1,400 crore. The Niva Bupa IPO price band is set between ₹70 and ₹74 per share, and investors must purchase a minimum of 200 shares for an investment of… Read More »Niva Bupa Health Insurance IPO GMP: Is This Your Next Profitable Investment?

Sagility IPO Review: Is This ₹2,107 Crore Healthcare IPO Your Next Big Profit Opportunity?

by Surya raghav

The Sagility IPO is set to launch on November 5, 2024, with plans to raise ₹2,107 crore through a complete offer-for-sale. The Sagility IPO price is fixed at ₹30 per share, requiring a minimum investment of ₹15,000 for retail investors. With 75% of the IPO reserved for institutional buyers, Sagility offers a unique chance within India’s healthcare sector. The company’s 12% revenue growth and 59% increase in profits for FY2024 make it a compelling investment… Read More »Sagility IPO Review: Is This ₹2,107 Crore Healthcare IPO Your Next Big Profit Opportunity?

PVR INOX Share Price Targets 2024-2030: Is Investing Now a Profit-Making Opportunity?

by Surya raghav

PVR INOX Ltd. is currently trading at approximately ₹1,585, reflecting a decline in share price amidst broader market fluctuations. Despite this, analysts have set ambitious PVR share price targets for the coming years, projecting ₹1,700 to ₹1,800 for 2024, ₹1,900 to ₹2,000 for 2025, and potentially ₹2,500 by 2030. The decline in INOX share price can be attributed to several factors, including changes in consumer behavior post-pandemic and increased competition in the entertainment sector. Nevertheless,… Read More »PVR INOX Share Price Targets 2024-2030: Is Investing Now a Profit-Making Opportunity?

Sun Pharma Share Price Target for 2024-2030 – Find Out Why Investors Are Excited!

by Surya raghav

Sun Pharmaceutical Industries Ltd has experienced fluctuations in its share price, currently trading around ₹1,766.15 after a 5% decline due to a preliminary injunction from a US court that delays the launch of its alopecia treatment drug, Leqselvi. Despite this setback, analysts project a sun pharma share price target of ₹1,900 to ₹2,000 for 2024. Expectations for continued growth lead to targets of ₹2,200 to ₹2,500 by 2028, and potentially reaching ₹3,000 by 2030. With… Read More »Sun Pharma Share Price Target for 2024-2030 – Find Out Why Investors Are Excited!

Motilal Oswal Share Price Targets for 2024-2030 – Is It Time to Invest?

by Surya raghav

Motilal Oswal Financial Services has been navigating fluctuations in its share price, with current targets indicating a potential range of ₹1,200 to ₹1,500 for 2024. This could gradually increase to ₹1,800 to ₹2,200 by 2028 and aim for ₹2,500 to ₹3,000 by 2030. Currently, the stock price is around ₹1,200, reflecting recent declines attributed to broader market volatility and concerns regarding its performance metrics. Investors should closely monitor these developments, as the company has a… Read More »Motilal Oswal Share Price Targets for 2024-2030 – Is It Time to Invest?